Artificial Intelligence , Articles & Publications

Dr. Andrew Lewis on AI, Leadership, and the Future of Pharmaceutical Innovation

In this new article by BioPharmaBoardroom, Dr. Andrew Lewis the Chief Scientific Officer at Quotient Sciences discusses the integration of AI into drug development.

AI in Drug Development: Balancing Innovation with Scientific Oversight

Drawing on its experience advancing an AI-designed drug product into clinical development, Quotient Sciences has seen how AI can accelerate formulation design, reduce drug substance requirements, and improve understanding of critical quality attributes.

Read the full article on BioPharmaBoardroom's website here.

Latest news from Quotient Sciences

More News

News & Announcements, Dr. Vanessa Zann Dr. Vanessa Zann featured as part of "Outsourcing Formulation Development & Manufacturing" Special Feature with Drug Development & Delivery By: Dr. Vanessa Zann

Artificial Intelligence, Dr. Andrew Lewis, Articles & Publications Dr. Andrew Lewis Featured in Pharma Fundamentals: Utilizing Artificial Intelligence in Drug Development By: Dr. Andrew Lewis

News & Announcements, Nottingham, UK, Artificial Intelligence Quotient Sciences Advances AI-Designed Drug Product into Clinical Development By: Dr. Andrew Lewis

More News

Your breakthrough therapy deserves momentum, and every day matters. Start a conversation with us today.